论文部分内容阅读
目的评价沃丽汀治疗玻璃体混浊的临床疗效。方法对18例玻璃体混浊患者予以沃丽汀片剂口服治疗,成人每日常规口服剂量为300～600μg,分3次服用,时间为3～10月。治疗前后对比检查视力、视野、眼部B超。结果治疗后随诊6～12个月。18例患眼15例视力得以提高,其中最佳矫正视力达0.8。视野明显有改善。结论沃丽汀治疗玻璃体混浊能改善患者的视力,提高患者的生活质量,是一种疗效显著的临床方法。
Objective To evaluate the clinical efficacy of Wollitin in the treatment of vitreous opacity. Methods Eighteen patients with vitreous opacity were treated with Wolimidine tablets orally. The daily oral dosage for adults was 300-600 μg, which was given in 3 doses for 3-10 months. Before and after treatment check visual acuity, visual field, eye B ultrasound. Results follow-up treatment of 6 to 12 months. Visual acuity was improved in 15 of 18 eyes, and the best corrected visual acuity was 0.8. Visual field obviously improved. Conclusion Wo Liting treatment of vitreous opacity can improve the patient’s vision and improve the quality of life of patients is a clinically effective method.